美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
41074 A II 2024/12/31 ZYDUS LIFESCIENCES LTD DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE USP
41077 A II 2024/12/31 MAITHRI DRUGS PRIVATE LTD SAPROPTERIN DIHYDROCHLORIDE
41081 A II 2024/12/31 DR REDDYS LABORATORIES LTD MAVACAMTEN
41086 A II 2024/12/31 METROCHEM API PRIVATE LTD VORTIOXETINE HYDROCHLORIDE
41088 A II 2024/12/31 SHANDONG LURUI PHARMACEUTICAL CO LTD METFORMIN HYDROCHLORIDE
41089 A II 2024/12/31 TRANSGEN BIOTECH CO LTD TRANSSTEM® CHEMICALLY DEFINED XENO-FREE CELL CRYOPRESERVATION MEDIUM III—DMSO FREE, PROTEIN FREE
41091 A II 2024/12/31 METROCHEM API PRIVATE LTD VORTIOXETINE HYDROBROMIDE
40611 A II 2024/12/30 ZHEJIANG TIANYU PHARMACEUTICAL CO LTD EDOXABAN TOSILATE
40633 A IV 2024/12/30 JIANGSU POLY PHARMACEUTICAL CO LTD BENZYL ALCOHOL USP/EP/BP/JP
40658 A II 2024/12/30 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD LUMEFANTRINE
40770 A II 2024/12/30 RAKS PHARMA PVT LTD PRIMIDONE USP
40873 A II 2024/12/30 SMS LIFESCIENCES INDIA LTD CIMETIDINE USP
40941 A II 2024/12/30 BOAI NKY MEDICAL HOLDINGS LTD POVIDONE–IODINE
40964 A II 2024/12/30 CIPLA LTD APIXABAN
41023 A II 2024/12/30 ANHUI TAIENKANG PHARMACEUTICAL CO LTD SEMAGLUTIDE
41027 A IV 2024/12/30 SHANDONG BANGKAI NEW MATERIALS CO LTD SILICON DIOXIDE USP
41030 A II 2024/12/30 STHREE CHEMICALS PRIVATE LTD OXCARBAZEPINE USP
41053 A II 2024/12/30 ZYDUS LIFESCIENCES LTD GABAPENTIN ENACARBIL
41054 A II 2024/12/30 ZYDUS LIFESCIENCES LTD SUVOREXANT
41079 A II 2024/12/30 MAITHRI DRUGS PRIVATE LTD MONOBASIC SODIUM PHOSPHATE ANHYDROUS USP

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files